SGLT2 Inhibitors vs. DPP4 Inhibitors: Study reveals new benefits of SGLT2i for prevention of hypertension
Japan: A recent study published in Hypertension Research using nationwide real-world data demonstrated the potential advantage of SGLT2 inhibitors over DPP4 inhibitors in reducing hypertension development in patients with diabetes. In the realm of hypertension management, the emergence of novel pharmacotherapies has sparked interest in their comparative effectiveness. Among these, sodium-glucose co-transporter 2 (SGLT2) inhibitors […]
